A 35-year-old woman with a 2-week history of hemoptysis, dyspnea, and hematuria (with RBC casts) presents with bilateral pulmonary infiltrates on chest X-ray and serum creatinine 2.8 mg/dL. Anti-GBM antibody serology is positive. Which investigation is most appropriate to confirm the diagnosis and assess disease severity in anti-GBM disease (Goodpasture syndrome)?
A. Serum and urine complement levels (C3, C4)
B. Chest CT with high-resolution imaging
C. Serum creatinine and estimated glomerular filtration rate trending
D. Kidney biopsy with immunofluorescence microscopy showing linear IgG deposition along the GBM
Explanation
Diagnosis and Confirmation of Anti-GBM Disease
Why Kidney Biopsy with IF is Definitive
Key Point
Kidney biopsy with immunofluorescence microscopy showing linear IgG deposition along the glomerular basement membrane (GBM) is the gold standard for confirming anti-GBM disease and assessing the degree of crescentic involvement.
Histopathologic Features of Anti-GBM Disease
Table
Microscopy Type
Characteristic Finding
Light Microscopy
Crescentic GN (cellular, fibrocellular, or fibrous crescents); segmental necrosis; capillary wall disruption
Immunofluorescence
Linear IgG deposition along the entire GBM (pathognomonic); often IgA, IgM, and C3 also present
Electron Microscopy
Electron-lucent widening of GBM; no immune deposits ("pauci-immune")
Clinical Pearl
The linear IF pattern is virtually diagnostic of anti-GBM disease and distinguishes it from ANCA-associated vasculitis (which shows pauci-immune pattern) and immune complex GN (granular deposits).
Why Biopsy Provides Both Diagnosis and Prognosis
High-YieldNEET PG
The percentage of crescents on biopsy is the strongest predictor of renal outcome and guides intensity of immunosuppression.
<50% crescents: Better prognosis; standard immunosuppression may suffice.
Serum anti-GBM antibody serology alone, though positive, does NOT assess glomerular involvement severity or the degree of crescentic disease. Biopsy is essential for prognostication.
Serum/urine complement levels: Complement is typically normal in anti-GBM disease (pauci-immune); complement depression suggests immune complex GN or ANCA-associated disease.
Chest CT: Assesses pulmonary involvement but does NOT confirm renal diagnosis or guide renal prognosis.
Serum creatinine and eGFR trending: Functional markers; do not provide histologic diagnosis or crescentic burden.
Mnemonic for Crescentic GN Patterns
ANCA — Pauci-immune (ANCA-associated vasculitis) Anti-GBM — Linear IgG (Goodpasture syndrome) Immune Complex — Granular deposits (lupus, PSGN, IgAN)
Tip
In a patient with positive anti-GBM serology, biopsy is mandatory to quantify crescents and guide treatment intensity. Plasmapheresis is indicated if >50% crescents or if serum creatinine >5.6 mg/dL.
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
